CRP and myocardial infarction: While the C-reactive protein (CRP) is assumed to be a good biomarker for evaluating the severity of inflammation of the vessel wall, it has conflicting results as a prognostic predictor in patients with myocardial infarction (MI): positively correlated in some studies (7, 8) but little correlated with prognosis in other studies (9–11).